Literature DB >> 32968306

[Non-ischemic ventricular dysfunction in COVID-19 patients: characteristics and implications for cardiac imaging on the basis of current evidence].

Donato Mele1, Antonello D'Andrea2, Marco Campana3, Giovanna Di Giannuario4, Filippo Flamigni1, Alessia Gimelli5, Georgette Khoury6, Massimiliano Rizzo7, Antonella Moreo8.   

Abstract

Coronavirus 2019 disease (COVID-19), caused by SARS-CoV-2, can lead to cardiac impairment with various types of clinical manifestations, including heart failure and cardiogenic shock. A possible expression of cardiac impairment is non-ischemic ventricular dysfunction, which can be related to different pathological conditions, such as myocarditis, stress and cytokine-related ventricular dysfunction. The diagnosis of these pathological conditions can be challenging during COVID-19; furthermore, their prevalence and prognostic significance have not been elucidated yet. The purpose of this review is to take stock of the various aspects of non-ischemic ventricular dysfunction that may occur during COVID-19 and of the diagnostic implications related to the use of cardiac imaging techniques.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32968306     DOI: 10.1714/3431.34196

Source DB:  PubMed          Journal:  G Ital Cardiol (Rome)        ISSN: 1827-6806


  3 in total

1.  COVID-19 Myocarditis: Prognostic Role of Bedside Speckle-Tracking Echocardiography and Association with Total Scar Burden.

Authors:  Antonello D'Andrea; Luigi Cante; Stefano Palermi; Andreina Carbone; Federica Ilardi; Francesco Sabatella; Fabio Crescibene; Marco Di Maio; Francesco Giallauria; Giancarlo Messalli; Vincenzo Russo; Eduardo Bossone
Journal:  Int J Environ Res Public Health       Date:  2022-05-12       Impact factor: 4.614

2.  Association of atrial fibrillation and left atrial volume index with mortality in patients with COVID-19 pneumonia.

Authors:  Antonello D'Andrea; Vincenzo Russo; Gianluca Manzo; Valerio Giordano; Marco Di Maio; Fabio Crescibene; Michele D'Alto; Eduardo Bossone
Journal:  Eur J Prev Cardiol       Date:  2022-03-11       Impact factor: 8.526

Review 3.  Myocarditis in COVID-19 patients: current problems.

Authors:  Donato Mele; Filippo Flamigni; Claudio Rapezzi; Roberto Ferrari
Journal:  Intern Emerg Med       Date:  2021-01-23       Impact factor: 5.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.